Arschang Valipour Selected Research

Arschang Valipour Research Topics

Disease

37	Chronic Obstructive Pulmonary Disease (COPD) 01/2023 - 06/2008
25	Emphysema 04/2024 - 01/2012
7	Lung Neoplasms (Lung Cancer) 09/2023 - 01/2019
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 01/2019
4	Pneumothorax 06/2023 - 01/2014
4	Neoplasms (Cancer) 06/2023 - 04/2018
4	Dyspnea (Shortness of Breath) 07/2021 - 12/2019
3	Inflammation (Inflammations) 01/2022 - 10/2008
2	Hypoxia (Hypoxemia) 06/2023 - 12/2004
2	Hypertension (High Blood Pressure) 04/2022 - 01/2021
2	Adenocarcinoma 01/2021 - 04/2018
2	Obstructive Sleep Apnea 12/2004 - 09/2003
1	Chronic Bronchitis 02/2024
1	Testicular Neoplasms (Testicular Cancer) 01/2023
1	Malignant Mesothelioma 04/2022
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022
1	Obstructive Lung Diseases (Obstructive Lung Disease) 01/2022
1	COVID-19 01/2022
1	Edema (Dropsy) 01/2022
1	Infections 12/2021
1	Noncommunicable Diseases 12/2021
1	Organizing Pneumonia 09/2021
1	Asthenia 01/2021
1	Fatigue 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Abdominal Pain (Pain, Abdominal) 01/2021
1	Brain Neoplasms (Brain Tumor) 01/2019
1	Fistula 01/2017
1	Heart Failure 09/2013
1	Fibrosis (Cirrhosis) 01/2012
1	Necrosis 10/2008
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2008
1	Abscess 05/2006

Drug/Important Bio-Agent (IBA)

6	GoldIBA 01/2022 - 01/2015
5	Bronchodilator Agents (Bronchodilators)IBA 02/2020 - 01/2017
4	salicylhydroxamic acid (SHAM)IBA 01/2022 - 12/2019
4	tiotropium-olodaterolIBA 07/2021 - 01/2019
3	Tyrosine Kinase InhibitorsIBA 04/2024 - 01/2019
3	EnzymesIBA 01/2022 - 09/2003
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 01/2018
3	C-Reactive ProteinIBA 12/2021 - 10/2008
2	NitrogenIBA 06/2023 - 12/2008
2	Immune Checkpoint InhibitorsIBA 06/2023 - 01/2023
2	brigatinibIBA 01/2021 - 01/2019
2	Anaplastic Lymphoma KinaseIBA 01/2021 - 11/2020
2	Interleukin-6 (Interleukin 6)IBA 01/2017 - 10/2008
2	Biomarkers (Surrogate Marker)IBA 10/2008 - 03/2003
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2008 - 12/2004
2	Anti-Bacterial Agents (Antibiotics)IBA 05/2006 - 03/2003
1	mobocertinibIBA 04/2024
1	Oxygen (Dioxygen)IBA 06/2023
1	Therapeutic UsesIBA 06/2023
1	InterferonsIBA 01/2023
1	CytokinesIBA 01/2023
1	AntigensIBA 01/2023
1	AeriSealIBA 11/2022
1	AsbestosIBA 04/2022
1	Prostaglandins EIBA 01/2022
1	AfatinibIBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	capmatinibIBA 01/2022
1	sotrovimabIBA 01/2022
1	CreatinineIBA 01/2022
1	Epidermal Growth Factor (EGF)IBA 01/2022
1	A-factor (Streptomyces)IBA 12/2021
1	Interleukin-33IBA 12/2021
1	InterleukinsIBA 12/2021
1	alectinibIBA 01/2021
1	selpercatinibIBA 01/2021
1	Muscarinic AntagonistsIBA 12/2020
1	lorlatinibIBA 11/2020
1	larotrectinibIBA 01/2020
1	Cholinergic Agents (Cholinergics)IBA 01/2020
1	CrizotinibIBA 01/2019
1	LigandsIBA 04/2018
1	Carbon MonoxideIBA 01/2018
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2017
1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 01/2017
1	Receptor for Advanced Glycation End ProductsIBA 06/2014
1	Advanced Glycation End ProductsIBA 06/2014
1	Glucose (Dextrose)FDA LinkGeneric 02/2014
1	PolymersIBA 04/2012
1	Blood Glucose (Blood Sugar)IBA 12/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2008
1	Fibrinogen (Factor I)FDA Link 10/2008
1	Hemostatics (Antihemorrhagics)IBA 06/2005

Therapy/Procedure

38	Therapeutics 09/2023 - 03/2003
21	Pneumonectomy (Lung Volume Reduction) 04/2024 - 01/2012
11	Denervation 01/2023 - 05/2015
2	Aftercare (After-Treatment) 01/2022 - 02/2020
2	Drug Therapy (Chemotherapy) 01/2020 - 12/2019
1	Retreatment 02/2024
1	Immunotherapy 01/2023
1	Combined Modality Therapy 04/2022
1	Nebulizers and Vaporizers (Inhaler) 12/2020
1	Radiofrequency Ablation 12/2019
1	Lung Transplantation 01/2017
1	Conservative Treatment 02/2014
1	Continuous Positive Airway Pressure 09/2013
1	Cardiac Catheters 06/2008